Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02118883 · ClinicalTrials.gov registry record · NA

Dehydration, Rehydration, and Blood Viscosity

A NA study of Dehydration, sponsored by Essentia Water.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02118883 is a NA study of Dehydration that has completed, run by Essentia Water. The registered enrollment target is 100 participants, above the 53-participant average among 20 other Dehydration trials with a reported enrollment target (89% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02118883, a NA study of Dehydration, has completed, sponsored by Essentia Water.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine and compare the rehydration effect of Essentia Water, an electrolyzed high-pH bottled water, with industry-standard bottled water purified by reverse osmosis with minerals added, on (1) whole blood viscosity, (2) plasma osmolality, (3) bioelectrical impedance analysis, and (4) body mass change, using serial measurements in apparently healthy adults following exercise-induced dehydration in a controlled environment.

Conditions Studied

Interventions

  • OTHER Essentia Water
  • OTHER Bottled water

Study Locations (1)

New Jersey

  • Health Onvector Inc - Camden

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-04
Est. Completion 2014-07
Phase NA

Sponsor

Essentia Water

1 total trials

What the Registry Record Tells You About NCT02118883

The ClinicalTrials.gov registry entry for NCT02118883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 53-participant average among 20 other Dehydration trials with a reported enrollment target (89% higher). The listed sponsor is Essentia Water, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 2 interventions - of which Essentia Water is the first listed.

NCT02118883 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02118883 about?

NCT02118883 is a clinical study titled "Dehydration, Rehydration, and Blood Viscosity". The purpose of this study is to examine and compare the rehydration effect of Essentia Water, an electrolyzed high-pH bottled water, with industry-standard bottled water purified by reverse osmosis with minerals added, on (1) whole blood viscosity, (2) plasma osmolality, (3) bioelectrical impedance ...

What is the current status of trial NCT02118883?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-04. Estimated completion is 2014-07.

What conditions does trial NCT02118883 study?

This clinical trial studies the following conditions: Dehydration.

What interventions are being tested in trial NCT02118883?

The interventions under investigation include: Essentia Water (OTHER), Bottled water (OTHER).

Who is sponsoring clinical trial NCT02118883?

This trial is sponsored by Essentia Water, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02118883 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.